🔗 Share this article

An underground market for unapproved slimming medications is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.

Investigational Drug Gaining Traction Via Social Media

The experimental drug, which remains in clinical trials, is being advertised by social media influencers for its supposed fat-burning effects. Followers are encouraged to contact these profiles directly for source information, while also receiving promotional offers.

Active Trade on Social Networks

Additionally, a flourishing market exists on Telegram, where communities with numerous of participants share “before and after” images, administration instructions and assertions of rapid British shipping. Sellers promote the substance there before redirecting customers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an investigational injection created by US drugmaker Eli Lilly. The drug targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials indicate it could help individuals reduce up to 25% of their body weight. Referred to as the “triple G”, the drug is being promoted digitally as the next Ozempic.

Medical Experts Voice Concerns

However, physicians and pharmacists have cautions that the sale of what is still an unapproved medication in the UK is a cause for concern and could result in individuals injecting products of uncertain source.

Some professionals stated the demand for the experimental drug could be linked to the rising cost of licensed slimming treatments such as Mounjaro.

Legal Position and Implementation

Marketing the unapproved drug on TikTok or messaging apps is illegal in the UK, as it is an unlicensed medication that must not be promoted or supplied for personal consumption under the British medical regulations.

Several content creators attempt to sidestep the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach pharmaceutical, advertising, and consumer laws, risking penalties, prosecution or imprisonment.

Service Response and Material Elimination

Based on TikTok, the platform has removed problematic content and prohibited related hashtags and search suggestions. The company stated it was dedicated to maintaining the platform secure and investing in enhancing enforcement strategies.

Online Trading Activities

Investigations also discovered communities with up to 9,000 members marketing the experimental drug using Telegram's built-in search feature, which functions like a public directory. Typing “retatrutide” immediately displays channels with thousands of members, filled with images of weight loss, glowing reviews and detailed guides for preparing or administering at residence.

Within moments of joining one group, a vendor posted contact information, where the majority of purchases occur. The vendor sent an instruction manual and guaranteed delivery within two days. When questioned whether the substance was genuine, one vendor responded: “You can’t be sure.” Another shared a image of a alleged testing documentation. Not one inquired about weight, health issues or previous experience.

Product Details and Costs

Within these communities, messages show dark colored packages with postal service stickers, claiming to contain new batches. One communication read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with purified liquid, or ready-to-use injectors usually sold at 160 pounds for 20mg. When questioned how long a injector should be used, vendors give contradictory responses ranging from a several days to “depends on your body”.

Service Moderation and Security Measures

A spokesperson for the messaging service said it actively monitored harmful material on its service including material that encouraged the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Medical Expert Cautions

“Individuals are injecting substances they cannot confirm. Even if the science behind this drug is sound, these digital products may not include what they advertise,” stated Jason Murphy, the director of pharmacy at Chemist4U.

A medical professional of an online medical service connected the surge in interest to current cost increases for approved weight-loss medications such as Mounjaro. “With prices rising, patients are turning to online platforms. But counterfeit injections are extremely risky. You can’t be certain what’s inside or whether the conditions they were produced in was clean,” she explained.

Her team has already encountered patients injured by personal administration from unverified sources. “We understand the disappointment, but purchasing from messaging apps or WhatsApp is gambling with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”

Manufacturer Position

A spokesperson from the pharmaceutical company said retatrutide was in phase 3 clinical trials and had not been reviewed or authorized by any regulatory agency anywhere in the world. “Therefore at this point no one can sell [it] for human use,” they said, noting that any product “falsely representing itself as a Lilly experimental product not yet authorized … may expose users to potentially serious medical dangers”.